Qube Research & Technologies Ltd - PRECIGEN INC ownership

PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 169 filers reported holding PRECIGEN INC in Q1 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of PRECIGEN INC
ValueSharesWeighting
Q4 2022$17,529
-77.5%
11,532
-80.1%
0.00%
-100.0%
Q2 2022$78,000
-93.8%
57,921
-90.3%
0.00%
-90.9%
Q1 2022$1,263,000
+351.1%
598,686
+693.4%
0.01%
+450.0%
Q4 2021$280,000
-43.0%
75,459
-23.4%
0.00%
-66.7%
Q3 2021$491,000
+350.5%
98,454
+491.0%
0.01%
+500.0%
Q2 2021$109,000
-70.8%
16,658
-69.2%
0.00%
-83.3%
Q1 2021$373,00054,1020.01%
Other shareholders
PRECIGEN INC shareholders Q1 2021
NameSharesValueWeighting ↓
Patient Capital Management, LLC 13,753,176$19,529,5101.15%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,078,220$2,951,0720.60%
EMFO, LLC 425,000$603,5000.57%
Opaleye Management Inc. 928,500$1,318,4700.43%
First Washington CORP 646,575$918,1370.37%
Fore Capital, LLC 426,791$606,0430.26%
SANDERS MORRIS HARRIS LLC 410,000$582,2000.12%
MSD Partners, L.P. 960,000$1,363,2000.11%
Virtus ETF Advisers LLC 79,754$113,2510.07%
CHIRON CAPITAL MANAGEMENT, LLC 55,850$79,3070.07%
View complete list of PRECIGEN INC shareholders